SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Wells Fargo Maintains Overweight on Cardlytics, Raises Price Target to $55

Wells Fargo maintains Cardlytics (NASDAQ:CDLX) with a Overweight and raises the price target from $45 to $55.

Benzinga · 05/12/2020 12:17

Wells Fargo maintains Cardlytics (NASDAQ:CDLX) with a Overweight and raises the price target from $45 to $55.